Govt exempts import duty on drugs, food for special medical purposes for personal use to treat rare diseases
时间:2024-06-26 11:27:51 阅读(143)
The government has exempted basic customs duty on all drugs and food for special medical purposes imported for personal use for treatment of rare diseases. The import duty waiver will come into effect from April 1. Also, the government has exempted Pembrolizumab (Keytruda), used in treatment of various cancers, from basic customs duty.
Drugs/Medicines generally attract basic customs duty of 10 per cent, while some categories of life saving drugs/vaccines attract a concessional rate of 5 per cent or Nil. “The Central Government has given full exemption from basic customs duty on all drugs and Food for Special Medical Purposes imported for personal use for treatment of all Rare Diseases listed under the National Policy for Rare Diseases 2021,” a finance ministry statement said.
While exemptions have already been provided to specified drugs for treatment of Spinal Muscular Atrophy or Duchenne Muscular Dystrophy, the government has been receiving many representations seeking customs duty relief for drugs and medicines used in treatment of other rare diseases.
Drugs or Special Foods required for the treatment of these diseases are expensive and need to be imported. The ministry said it is estimated that for a child weighing 10 kg, the annual cost of treatment for some rare diseases, may vary from Rs 10 lakh to more than Rs 1 crore per year with treatment being lifelong and drug dose and cost, increasing with age and weight.
“This exemption will result in substantial cost savings and provide much needed relief to the patients,” the ministry said.
上一篇:Mehta Equities’ stocks recommendation for the week
下一篇:Zomato, PNB, KPI Green Energy, TVS Motor, TCS, Apollo Hospitals, Wipro stocks in focus on F&O expiry
猜你喜欢
- Adani stocks are getting no love from India’s money managers
- Markets Wrap – Thu, 29 Dec ‘22- Stocks rise, rupee appreciates; Asia, Europe markets, Gold, Crude, Crypto updates
- Adani Ports, PVR, Tata Power, UPL, Reliance, BPCL, Ami Lifesciences stocks in focus on 16 September 2022
- Markets Wrap – Tue, 14 Mar ‘23- Nifty, Sensex fall, rupee depreciates; Asia, US markets, Gold, Crude updates
- Markets Wrap – Mon, 20 Feb ‘23- Nifty, Sensex plunge, rupee rises; Asia, US markets, Gold, Crude updates
- Kotak Mahindra Bank, LIC, Godrej Properties, NTPC, Titan, Tata Steel, Adani Green stocks in focus
- Kotak Mahindra Bank drops over 2% after naming outsider as new CEO
- MCX gold at all-time highs, difficult to predict future levels, still not overbought; dollar to lose value
- JK Tyre & Industries raises Rs 500 crore through QIP